ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial.

Margarita Majem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.